Home
/

What is a Progesterone Blood Test?

REVIEWED BY
Bill Maish, MD
Clinical Content Consultant
Published
May 30, 2026
Last updated
May 30, 2026
Quick answer:

Progesterone is a cholesterol-derived steroid hormone produced by the ovarian corpus luteum after ovulation and by the placenta during pregnancy; a blood test measures circulating levels to confirm ovulation and assess luteal or placental function. Low mid-luteal values reflect anovulation or weak corpus luteum activity, which may contribute to irregular bleeding, PMS, sleep disturbance, and difficulty conceiving. Progesterone interpreted alongside cycle timing and other hormones supports assessment of ovulation status and reproductive health.

Read more →
Table of contents

Progesterone: The Post-Ovulation Steroid Signal

Progesterone is a natural hormone made mainly by the ovaries after ovulation, and by the placenta during pregnancy; smaller amounts come from the adrenal glands (and testes). It is a cholesterol-derived steroid (a C21 progestogen) that circulates in the bloodstream bound to carrier proteins. A progesterone blood test simply measures how much of this hormone is present in your blood at a given moment, offering a direct readout of current production by these tissues (corpus luteum, placenta, adrenal cortex).

Progesterone's central job is to prepare and stabilize the uterine lining and support early pregnancy (endometrial maturation, implantation, uterine quiescence). It also times the menstrual cycle's second half (luteal phase), tempers estrogen's growth signals, and slightly raises body temperature. Beyond reproduction, it serves as a building block for other steroid hormones (cortisol, aldosterone) and acts in the brain as a calming signal (neuroactive steroid). Because of these roles, blood levels mirror ovulation status and luteal/placental activity, and more broadly the balance of steroid hormone pathways.

Why Progesterone Is More Than a Fertility Marker

Progesterone is a steroid hormone that signals whether the body has ovulated and whether the uterus, brain, immune system, and metabolism have shifted into the post-ovulation, pro-gestational mode. It stabilizes the uterine lining, modulates brain GABA receptors (calming and sleep), raises basal temperature, slows gut motility, and tempers inflammatory tone—so it's a whole-system status indicator, not just a fertility marker.

Cycle-Phase Patterns: Pre-Ovulation, Luteal, and Pregnancy

Reference ranges depend on timing. Values are very low before ovulation, rise into a higher luteal range after ovulation, and climb progressively in pregnancy; men and children typically have low, steady values. When ovulation has occurred, healthy patterns tend to sit in the mid-to-upper part of the luteal range and show a clear rise from pre-ovulatory levels.

When results stay low after mid-cycle, it often reflects anovulation or a weak corpus luteum. The endometrium may be unstable, leading to irregular or heavy periods, spotting, PMS, sleep disturbance, anxiety, or migraines; over time, "unopposed estrogen" symptoms can appear. In teens (early cycles) and perimenopause, anovulatory cycles make low luteal progesterone common. In pregnancy, low values may suggest inadequate placental or luteal support. In men and children, unusually low levels can hint at impaired adrenal steroidogenesis.

Higher values are expected in the luteal phase and especially in pregnancy. Outside these contexts, elevated levels may reflect progesterone medication, a corpus luteum cyst, or—rarely—ovarian or adrenal sources. Symptoms can include fatigue, lightheadedness, breast tenderness, bloating, constipation, and warmth.

Being in range suggests appropriate ovarian or placental production for the physiologic state. In cycling women, mid-to-high luteal-phase values about a week after ovulation indicate recent ovulation and adequate endometrial support. In pregnancy, trimester-specific ranges track placental function. In males and postmenopausal adults, low stable values are expected.

Timing, Contraception, and Assay Variability

Timing is critical—secretion is pulsatile and cycle-dependent—so single values fluctuate. Hormonal contraception suppresses levels; progesterone therapy raises them. Some immunoassays cross-react; LC-MS/MS is more specific. hCG, estradiol, and ultrasound often supply needed context.

Big picture: progesterone integrates ovarian, placental, adrenal, brain, and immune signals. Interpreting it alongside cycle timing, hCG in pregnancy, LH/FSH, estradiol, and thyroid markers clarifies reproductive status, endocrine resilience, and long-term risks linked to cycle quality and endometrial health.

What a Progesterone Result Reveals About Your Cycle and Beyond

A progesterone blood test measures the level of this ovarian and placental steroid. Progesterone stabilizes the uterine lining, calms neural circuits via GABA, slightly raises body temperature, and modulates immune tolerance—linking it to reproduction, sleep and mood, metabolism, and cardiovascular tone.

FAQs

Progesterone testing is a blood test (serum progesterone) that measures circulating progesterone. It helps confirm ovulation, gauge luteal phase strength, and contextualize hormone balance.

Testing can verify ovulation, assess luteal support for implantation, explore irregular bleeding or PMS/PMDD, guide estrogen use, monitor therapy, and add context for steroid hormone balance in males.

For cycle tracking or fertility, a mid-luteal sample about seven days after ovulation is common. Irregular cycles may benefit from serial tests, and repeating can help when timing is uncertain.

Cycle phase, pregnancy, anovulation, thyroid or prolactin disorders, stress, low energy availability, training load, and medications (including progestins or androgens) can influence results.

Fasting is not typically required. The key is timing—aim for the mid-luteal phase after confirmed ovulation. Note cycle day, ovulation signs, medications, and symptoms.

Superpower currently offers at-home blood testing in the following states: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, and Wisconsin.

We’re actively expanding nationwide, with new states being added regularly. If your state isn’t listed yet, stay tuned.

References

  1. Practice Committees of the American Society for Reproductive Medicine and the Society for Reproductive Endocrinology and Infertility. (2021). Diagnosis and treatment of luteal phase deficiency: A committee opinion. Fertility and Sterility, 115(6), 1416-1423. https://doi.org/10.1016/j.fertnstert.2021.02.010
  2. Marques, P., De Sousa Lages, A., Skorupskaite, K., Rozario, K. S., Anderson, R. A., & George, J. T. (2024). Physiology of GnRH and gonadotrophin secretion. In Endotext. MDText.com. https://www.ncbi.nlm.nih.gov/books/NBK279070/
  3. Harlow, S. D., Gass, M., Hall, J. E., Lobo, R., Maki, P., Rebar, R. W., Sherman, S., Sluss, P. M., & de Villiers, T. J. (2012). Executive summary of the Stages of Reproductive Aging Workshop + 10: Addressing the unfinished agenda of staging reproductive aging. Menopause, 19(4), 387-395. https://doi.org/10.1097/gme.0b013e31824d8f40
  4. Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., & White, P. C. (2018). Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 103(11), 4043-4088. https://doi.org/10.1210/jc.2018-01865
  5. Rosner, W., Auchus, R. J., Azziz, R., Sluss, P. M., & Raff, H. (2007). Position statement: Utility, limitations, and pitfalls in measuring testosterone: An Endocrine Society position statement. The Journal of Clinical Endocrinology & Metabolism, 92(2), 405-413. https://doi.org/10.1210/jc.2006-1864

Built by the world’s top doctors and scientists

Dr Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

Learn more

Dr Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

Learn more

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

Learn more

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

Learn more
Membership slide 1
Membership slide 1
Membership slide 2
Membership slide 3
1 / 3

Your membership starts here

Annual 100+ biomarker panel

Data dashboard and digital twin

Upload past labs and connect wearables

Personalized health protocol

24/7 care team access

AI companion for all health questions

Marketplace with additional solutions

$199

/year*

Billed annually

HSA/ FSA eligible
Cancel anytime
Results in a week

* Pricing may vary for members in New York and New Jersey